Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
Background
Cited by
Items 701–800 of 1,003
Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity
Strickland, M. R., Alvarez-Breckenridge, C. A., Gainor, J. F., & Brastianos, P. K. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0976 · Cited by 59
Virgone-Carlotta, A., Uhlrich, J., Akram, M. N., Ressnikoff, D., Chrétien, F., Domenget, C., Gherardi, R., Despars, G., Jurdic, P., Honnorat, J., et al. (2013) · Glia · doi:10.1002/glia.22546 · Cited by 50
“These results suggest that microglia exerts a microphagocytic activity toward TH1 neurons in the injured SNc. Discussion A number of studies demonstrated the deleterious role of microglia in the murine MPTP model of PD (Cardona et al., 2006; Gao et al., 2003; Sriram et al., 2002; Wu et al., 2002).”
BackgroundInfluentialThe Effects of Age and Cx 3 cr1 Deficiency on Retinal Microglia in the Ins2 Akita Diabetic Mouse
Kezic, J. M., Chen, X., Rakoczy, E. P., & McMenamin, P. G. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10876 · Cited by 54
Kane, C. J. M., & Drew, P. D. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0416-171r · Cited by 60
“CX3CR1deficient mice exhibit increased microglial activation and neurotoxicity [82].”
BackgroundMKEY, a Peptide Inhibitor of CXCL4‐CCL5 Heterodimer Formation, Protects Against Stroke in Mice
Fan, Y., Xiong, X., Zhang, Y., Yan, D., Jian, Z., Xu, B., & Zhao, H. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003615 · Cited by 52
The flavonoid rutin modulates microglial/macrophage activation to a CD150/CD206 M2 phenotype
da Silva, A. B., Coelho, P. L. C., Amparo, J. A. O., de Almeida, M. M. A., Borges, J. M. P., Souza, C. D. S., Costa, M. D. F. D., Mecha, M., Rodriguez, C. G., da Silva, V. D. A., et al. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.07.004 · Cited by 61
Sun, S., Yu, H., Yu, H., Mei, H., Ni, W., Zhang, Y., Guo, L., He, Y., Xue, Z., Ni, Y., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8712-y · Cited by 57
Luhmann, U. F. O., Carvalho, L. S., Robbie, S. J., Cowing, J. A., Duran, Y., Munro, P. M. G., Bainbridge, J. W. B., & Ali, R. R. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2012.11.015 · Cited by 50
“This is supported by studies in which enhanced neuronal cell death and microglial activation was observed in Cx3cr1GFP/GFP mice following induction by peripheral injection of LPS (Cardona et al., 2006).”
ResultNeuron-macrophage crosstalk in the intestine: a “microglia” perspective
Verheijden, S., Schepper, S. D., & Boeckxstaens, G. E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00403 · Cited by 59
“Its role in the control of inflammatory cytokine production by microglia has been proven to be therapeutically relevant in several models of neurodegenerative disorders including Alzheimer’s and Parkinson’s disease (Cardona et al., 2006; Lee et al., 2010).”
BackgroundWang, J.-Y., Huang, Y.-N., Chiu, C., Tweedie, D., Luo, W., Pick, C. G., Chou, S.-Y., Luo, Y., Hoffer, B. J., Greig, N. H., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0631-6 · Cited by 55
“Annexin V binds strongly with PS, and its detection has been widely used for imaging of apoptosis both in vitro and in vivo; thus, to label external PS, we stained for the protein annexin V [35, 36].”
MethodWang, L., Liu, Y., Yan, S., Du, T., Fu, X., Gong, X., Zhou, X., Zhang, T., & Wang, X. (2020) · Aging and disease · doi:10.14336/ad.2019.0615 · Cited by 49
“Aging and Disease • Volume 11, Number 2, April 2020 255 exacerbated neuroinflammation and neurodegeneration in PD models [9, 10].”
BackgroundAnwar, M. M. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3673 · Cited by 61
Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease
Camacho-Hernández, N. P., & Peña‐Ortega, F. (2023) · Neural Plasticity · doi:10.1155/2023/4637073 · Cited by 60
“Spinal cord or spinal nerve injury (Figure 2), along with intraperitoneal administration of LPS, induces the overexpression of FKN and CX3CR1 in neurons and microglia, respectively, without changes in either of them in astrocytes [32, 90, 94, 95].”
BackgroundInfluentialSárvári, M., Kalló, I., Hrabovszky, E., Solymosi, N., Tóth, K., Likó, I., Molnar, B. A., Tihanyi, K., & Liposits, Z. (2010) · Endocrinology · doi:10.1210/en.2010-0375 · Cited by 54
Munoz, L. E., Peter, C., i, M. H., Wesselborg, S., & Lauber, K. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.11.016 · Cited by 59
Pimentel‐Coelho, P. M., Michaud, J.-P., & Rivest, S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0535-13.2013 · Cited by 52
“CX3CR1 KO adult mice have an increased neuronal loss in several animal models of neurological disease (Cardona et al., 2006; Blomster et al., 2011), although they exhibit decreased neuronal damage after traumatic spinal cord injury (Donnelly et al.”
BackgroundTherapeutic Potential of Perineural Invasion, Hypoxia and Desmoplasia in Pancreatic Cancer
Liu, H., Ma, Q., Xu, Q., Lei, J., Li, X., Wang, Z., & Wu, E. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128112092395 · Cited by 57
“CX3CR1 exclusively binds the transmembrane chemokine CX3CL1 expressed by neurons, nerve fibers and activated endothelial cells [44–47].”
BackgroundImpaired microglia fractalkine signaling affects stress reaction and coping style in mice
Winkler, Z., Kuti, D., Ferenczi, S., Gulyás, K., Polyák, Á., & Kovács, K. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.023 · Cited by 50
Enhanced fear and altered neuronal activation in forebrain limbic regions of CX3CR1-deficient mice
Schubert, I., Ahlbrand, R., Winter, A., Vollmer, L., Lewkowich, I., & Sah, R. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.09.013 · Cited by 49
CCL17 exerts a neuroimmune modulatory function and is expressed in hippocampal neurons
Fülle, L., Offermann, N., Hansen, J. N., Breithausen, B., Erazo, A. B., Schanz, O., Radau, L., Gondorf, F., Knöpper, K., Alferink, J., et al. (2018) · Glia · doi:10.1002/glia.23507 · Cited by 56
Liu, Y., Zhang, T., Meng, D., Sun, L., Yang, G., He, Y., & Zhang, C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112371 · Cited by 57
Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis
Plastini, M. J., Desu, H. L., & Brambilla, R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00269 · Cited by 48
“Its ablation leads to increased microglial activation which parallels an early EAE onset and a more severe clinical course (Cardona et al., 2006; Wlodarczyk et al., 2015).”
BackgroundMicroglia Signatures: A Cause or Consequence of Microglia-Related Brain Disorders?
Mirarchi, A., Albi, E., & Arcuri, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010951 · Cited by 54
“Microglia uniquely express CX3CR1 in the brain, a receptor important for immunomodulation under normal conditions; its genetic removal leads to neurotoxicity [96].”
BackgroundEAAT expression by macrophages and microglia: still more questions than answers
Gras, G., Samah, B., Hubert, A., Léone, C., Porcheray, F., & Rimaniol, A. (2011) · Amino Acids · doi:10.1007/s00726-011-0866-6 · Cited by 49
“it is not necessary for monocyte migration toward the CNS, neuron-expressed fractalkine (CX3CL1) contributes to repression ( Cardona et al. 2006 ), concordant with the proposal that microglia precursor in the blood may be the CCR2 - /CX3CR1 ? monocyte subpopulation (Geissmann”
BackgroundFletcher, E. L. (2020) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12671 · Cited by 54
“Notably, when cx3cr1 is genetically ablated in mouse models of neurodegeneration, the extent of neural loss is greater than when cx3cr1 is present.(22) Similarly, when fractalkine-cx3cr1 signalling is absent in the retina, such as in cx3cr1-null mice there is loss of cone photoreceptor integrity during visual maturati…”
Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
Pak, V. M., Onen, S. ‐., Bliwise, D. L., Kutner, N. G., Russell, K. L., & Onen, F. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00069 · Cited by 56
Fujita, Y., Nakanishi, T., Ueno, M., Itohara, S., & Yamashita, T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107580 · Cited by 54
Milde, S., van Tartwijk, F. W., Vilalta, A., Hornik, T. C., Dundee, J. M., Puigdellívol, M., & Brown, G. C. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02280-2 · Cited by 47
Kezic, J., Xu, H., Chinnery, H. R., Murphy, C. C., & McMenamin, P. G. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0953 · Cited by 48
Cyrino, L. A. R., de Lima, D. D., Ullmann, O. M., & Maia, T. P. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.609487 · Cited by 59
Neuron-Derived Extracellular Vesicles Modulate Microglia Activation and Function
Peng, H., Harvey, B. T., Richards, C. I., & Nixon, K. (2021) · Biology · doi:10.3390/biology10100948 · Cited by 58
Fekete, R., Simats, A., Bíró, E., Pósfai, B., Cserép, C., Schwarcz, A. D., Szabadits, E., Környei, Z., Tóth, K., Fichó, E., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01871-z · Cited by 64
“5a,b), suggesting that systemic inflammation might compromise microglial inflammatory responses via the CX3CR1–CX3CL1 axis 38,39 .”
Complement Factor H, a Marker of Self Protects against Experimental Autoimmune Encephalomyelitis
Griffiths, M. R., Neal, J. W., Fontaine, M., Das, T., & Gasque, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800205 · Cited by 47
Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis
Noda, M., & Suzumura, A. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/891087 · Cited by 47
“chemokine fractalkine receptor CX3CR1, is almost exclusively expressed in microglia throughout the CNS, which is involved in progression of neurodegenerative disease by altering microglial activities [16, 17] (Figure 2).”
BackgroundModeling CNS microglia: the quest to identify predictive models
Carson, M. J., Crane, J., & Xie, A. X. (2008) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2008.07.006 · Cited by 56
“Knockout and transgenic overexpression mice have confirmed in vivo the significance of these neuronal–microglial interactions for limiting neurotoxic microglial activation states and promoting the resolution of acute neuroinflammatory responses in the CNS [11–13] Thus, once these receptor–ligand interactions are docum…”
BackgroundTen years of Nature Reviews Neuroscience: insights from the highly cited
Luo, L., Rodríguez, E., Jerbi, K., Lachaux, J.-P., Martinerie, J. M., Corbetta, M., Shulman, G. L., Piomelli, D., Turrigiano, G. G., Nelson, S. B., et al. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2912 · Cited by 50
“Neuron–microglia signals are now a major point of interest, with fractalkin”
BackgroundAlzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
Streit, W. J., & Xue, Q.-S. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00138 · Cited by 47
Tracking Retinal Microgliosis in Models of Retinal Ganglion Cell Damage
Liu, S., Li, Z.-W., Weinreb, R. N., Xu, G., Lindsey, J. D., Ye, C., Yung, W., Pang, C., Lam, D. S. C., & Leung, C. K.-S. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9450 · Cited by 47
Tian, L., Hui, C. W., Bisht, K., Tan, Y., Sharma, K. P., Chen, S., Zhang, X., & Tremblay, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.007 · Cited by 52
Zhang, L., Xu, J., Gao, J., Wu, Y., Yin, M., & Zhao, W. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0084 · Cited by 47
Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis
Liu, C., Hong, K., Chen, H., Niu, Y., Duan, W., Liu, Y., Ji, Y., Deng, B., Li, Y., Li, Z., et al. (2019) · Biological Chemistry · doi:10.1515/hsz-2018-0204 · Cited by 47
Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., Hu, C. K., Tran, K. V., Miguel, Z. D., Chien, B. Y., & Sapolsky, R. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4705-12.2013 · Cited by 46
“Mononuclear cells were extracted from adult brains as described previously (Cardona et al., 2006a).”
MethodInfluentialCX3CL1 (Fractalkine) Protein Expression in Normal and Degenerating Mouse Retina: In Vivo Studies
Zieger, M. V., Ahnelt, P. K., & Uhrín, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106562 · Cited by 47
“Strong evidence indicates that soluble fractalkine prevents NMethyl-D-aspartate-neurotoxicity [18,27,33].”
BackgroundMicroglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke
Zeyen, T., Noristani, R., Habib, S. A. J., Heinisch, O., Slowik, A., Huber, M., Schulz, J. B., Reich, A., & Habib, P. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01916-9 · Cited by 51
Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington’s Disease
Kim, A., García-García, E., Straccia, M., Comella-Bolla, A., Miguez, A., Masana, M., Alberch, J., Canals, J. M., & Rodríguez, M. J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00163 · Cited by 46
“FKN modulates microglial motility, migration and activation by interaction with CX3CR1, its only specific receptor that in the brain parenchyma is restricted to microglia (Cardona et al., 2006; Chiu et al., 2013).”
BackgroundHigh Expression of CX3CL1/CX3CR1 Axis Predicts a Poor Prognosis of Pancreatic Ductal Adenocarcinoma
Xu, X., Wang, Y., Chen, J., Ma, H., Shao, Z., Chen, H., & Jin, G. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-1921-7 · Cited by 47
“CX3CL1 is one of the most expressed chemokines in the central nervous system, where it regulates the communication between neurons, glia, and microglia.(14,15) Over the past few years, the correlation between chemokines and tumor progression has been studied very extensively.”
BackgroundAlzheimer’s genes in microglia: a risk worth investigating
Sudwarts, A., & Thinakaran, G. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00679-4 · Cited by 44
“CX3CR1 signalling limits inflammatory responses to LPS [263], suggesting the neuronal release of fractalkine initiates a reparative microglial programme.”
BackgroundBo, W., Cheng, G., Bi, Q., Lu, C. C., Sun, Q., Li, L., Chen, N., Hu, M., Lu, H., Xu, X., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.07.011 · Cited by 54
Basic Aspects of the Immunology of Neuroinflammation
Wohleb, E. S., & Godbout, J. P. (2013) · Modern trends in psychiatry · doi:10.1159/000343964 · Cited by 60
Piccinin, S., Angelantonio, S. D., Piccioni, A., Volpini, R., Cristalli, G., Fredholm, B. B., Limatola, C., Eusebi, F., & Ragozzino, D. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.012 · Cited by 50
Immig, K., Gericke, M., Menzel, F., Merz, F., Krueger, M., Schiefenhövel, F., Lösche, A., Jäger, K., Hanisch, U., Biber, K., et al. (2015) · Glia · doi:10.1002/glia.22771 · Cited by 45
“…microglia contain a higher percentage of cells expressing CX3CR1 and F4/80, which are known as markers for resident macrophages and microglia (Cardona et al., 2006; Carson et al., 1998; Harrison et al., 1998; Jung et al., 2000; Lewis et al., 2011; Niess, 2005; Prinz et al., 2011; Wlodarczyk…”
BackgroundGuha, S. K., Tillu, R., Sood, A., Patgaonkar, M. S., Nanavaty, I. N., Sengupta, A., Sharma, S., Vaidya, V. A., & Pathak, S. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.009 · Cited by 48
“This observation is noteworthy as microglia not only exhibits phagocytosis-dependent regulation of adult hippocampal neurogenesis (Sierra et al., 2010), but also share contact dependent and independent interaction with neurons within the CNS (Hoek et al., 2000; Wright et al., 2000; Cardona et al., 2006; Bessis et al.,…”
BackgroundInfluentialWalter, H. L., van der Maten, G., Antunes, A. R. P., Wieloch, T. W., & Ruscher, K. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0232-1 · Cited by 48
“The sole receptor for FKN is CX3C chemokine receptor 1 (CX3CR1) and is expressed on different immune cell populations including microglia [9,14-16].”
BackgroundYamada, J., Nakanishi, H., & Jinno, S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.030 · Cited by 51
“Reactive microglial cells kill and phagocytose target neuronal cells following excessive and uncontrolled adverse stimulation (van Rossum and Hanisch, 2004; Cardona et al., 2006).”
Schizophrenia associated sensory gating deficits develop after adolescent microglia activation
Eßlinger, M., Wachholz, S., Manitz, M. P., Plümper, J., Sommer, R., Juckel, G., & Friebe, A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.018 · Cited by 47
Wang, Y., Zhou, K., Li, T., Xu, Y., Xie, C., Sun, Y., Zhang, Y., Rodríguez, J., Blomgren, K., & Zhu, C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.120 · Cited by 46
Wei, L., Tokizane, K., Konishi, H., Yu, H., & Kiyama, H. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0970-y · Cited by 49
van Ton, A. M. P., Verbeek, M. M., Alkema, W. B. L., Pickkers, P., & Abdo, W. F. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.027 · Cited by 49
“Fractalkine signaling was found to suppress the neuroinflammatory response by decreasing pro-inflammatory cytokine production (Cardona et al., 2006; Zujovic et al., 2000) and is therefore important for CNS homeostasis.”
BackgroundBrandi, E., Torres-Garcia, L., Svanbergsson, A., Haikal, C., Liu, D., Li, W., & Li, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.910988 · Cited by 58
Microglia: Synaptic modulator in autism spectrum disorder
Hu, C., Li, H., Li, J., Luo, X., & Hao, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.958661 · Cited by 60
Is membrane homeostasis the missing link between inflammation and neurodegenerative diseases?
de Groot, N. S., & Torrent, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2038-4 · Cited by 46
“knockout mouse models of PD also reveal the worsening of the phenotype [30], suggesting that the modulation of 4798 N.”
BackgroundCX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes
Catalano, M., Lauro, C., Cipriani, R., Chece, G., Ponzetta, A., Angelantonio, S. D., Ragozzino, D., & Limatola, C. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.07.020 · Cited by 48
“…encephalitis (Huang et al., 2006), superoxide dismutase mutants, lipopolysaccharide-mediated neuroinflammation, toxin-induced Parkinsonlike disease (Cardona et al., 2006), stroke (Soriano et al., 2002; Dénes et al., 2008; Cipriani et al., 2011) and Alzheimer disease (Lee et al., 2008; Bhaskar et…”
BackgroundInfluentialSeo, Y., Kim, H., Kang, I., Choi, S. W., Shin, T., Shin, J., Lee, B., Lee, J. Y., Kim, J.-J., Kook, M. G., et al. (2016) · Glia · doi:10.1002/glia.23077 · Cited by 45
“In addition, when Cx3cl1–Cx3cr1 signaling was disrupted in the murine brain via knockout of Cx3cr1, the neurological symptoms of Alzheimer’s disease and amyotrophic lateral sclerosis were exacerbated by enhanced microglial neurotoxic activity (Cardona et al., 2006).”
BackgroundInfluentialSelf-citationMicroglia Function in the Normal Brain
Rommy von Bernhardi, M., Heredia, F., Salgado, N., & Muñoz, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7_4 · Cited by 54
Immune mechanisms of stress susceptibility and resilience: Lessons from animal models
Tsyglakova, M., McDaniel, D. K., & Hodes, G. E. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100771 · Cited by 49
Ruitenberg, M. J., Vukovic, J., Blomster, L. V., Hall, J. M., Jung, S., Filgueira, L., McMenamin, P. G., & Plant, G. W. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.010 · Cited by 46
“Several studies have shown that CX3CL1 signalling can be neuroprotective and inhibit production of deleterious pro-inflammatory molecules (Meucci et al., 1998; Mizuno et al., 2003; Cardona et al., 2006).”
BackgroundSelf-citationThe effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases
Triviño, J. J., & von Bernhardi, R. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104982 · Cited by 43
Deng, M., Yang, H., Xie, X., Liang, G., & Gan, L. (2014) · Gene Expression Patterns · doi:10.1016/j.gep.2014.03.001 · Cited by 44
“Since NeuN is a mature neurons marker throughout the nervous system of mice (Cardona et al., 2006; Hafezparast et al., 2003; Karsten et al., 2006; Mullen et al., 1992), we also compared the spatiotemporal expression pattern of POU4F2 and NeuN during CVG development.”
BackgroundHoriuchi, M., Smith, L., Maezawa, I., & Jin, L.-W. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.02.014 · Cited by 43
Griffiths, M., Botto, M., Morgan, B. P., Neal, J., & Gasque, P. (2018) · Immunology · doi:10.1111/imm.12974 · Cited by 47
Hattori, Y., & Miyata, T. (2018) · Genes to Cells · doi:10.1111/gtc.12632 · Cited by 44
“Microglia, the immune cells that reside in the central nervous system, play multiple roles in the adult brain: maintaining homeostasis by clearing damaged cells and debris, building up neuronal networks by modulating synaptic connections, and controlling production of neurons (Cardona et al., 2006; Hanisch & Kettenman…”
BackgroundEnomoto, S., & Kato, T. A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104921 · Cited by 46
de Cossío, L. F., Lacabanne, C., Bordeleau, M., Castino, G., Kyriakakis, P., & Tremblay, M. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.025 · Cited by 43
The effect of lipid nanoparticle PEGylation on neuroinflammatory response in mouse brain
Huang, J.-Y., Lu, Y., Wang, H., Liu, J., Liao, M.-H., Hong, L.-J., Tao, R., Ahmed, M. M., Liu, P., Liu, S.-S., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.009 · Cited by 44
Thomas, D. M., Francescutti, D. M., & Kuhn, D. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05421.x · Cited by 47
“for fractalkine (CX3CR1) were hypersensitive to the damaging effects of MPTP on DA neurons of the substantia nigra (Cardona et al. 2006).”
BackgroundResultInfluentialYazdani, S., Mariosa, D., Hammar, N., Andersson, J., Ingre, C., Walldius, G., & Fang, F. (2019) · Annals of Neurology · doi:10.1002/ana.25614 · Cited by 42
Delpech, J.-C., Saucisse, N., Parkes, S. L., Lacabanne, C., Aubert, A., Casenave, F., Coutureau, É., Sans, N., Layé, S., Ferreira, G., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3028-14.2015 · Cited by 47
“Here, we activated microglia locally with LPS, a potent inflammatory agent (Cardona et al., 2006; Haynes, 2006; Pascual et al., 2012), and monitored cellular and behavioral consequences.”
Age- and Light-Dependent Development of Localised Retinal Atrophy in CCL2−/−CX3CR1GFP/GFP Mice
Chen, M., Hombrebueno, J. R., Luo, C., Penalva, R., Zhao, J., Colhoun, L., Pandi, S. P. S., Forrester, J. V., & Xu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061381 · Cited by 42
“The CX3CL1-CX3CR1 pathway is known to play an important role in regulating microglial activation [48], and is neuroprotective CCL2 and CX3CR1 in Retinal Degeneration”
BackgroundVázquez, C., Tolón, R. M., Pazos, M. R., Moreno, M., Koester, E. C., Cravatt, B. F., Hillard, C. J., & Romero, J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.005 · Cited by 48
“Cx3cr1 is expressed by monocytes, dendritic cells and by microglia in the CNS and plays a relevant role in the neurotoxic processes mediated by these cells (Cardona et al, 2006).”
BackgroundThe Glucocorticoid Receptor Is a Critical Regulator of HIV Latency in Human Microglial Cells
Alvarez-Carbonell, D., Ye, F., Ramanath, N., Dobrowolski, C. N., & Karn, J. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9798-1 · Cited by 42
Compta, Y., Dias, S. P., Giraldo, D. M., Pérez‐Soriano, A., Muñoz, E., Saura, J., Fernández, M., Bravo, P., Cámara, A., Pulido-Salgado, M., et al. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.05.040 · Cited by 47
Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenaline
González‐Prieto, M., Gutiérrez, I. L., García‐Bueno, B., Caso, J. R., Leza, J. C., Ortega‐Hernández, A., Gómez‐Garré, D., & Madrigal, J. L. M. (2020) · Glia · doi:10.1002/glia.23885 · Cited by 48
“, 2015), amyotrophic lateral sclerosis (Cardona et al., 2006; C. Liu et al., 2019), endotoxemia (Cardona et al.”
BackgroundInfluentialTweedie, D., Karnati, H. K., Mullins, R. J., Pick, C. G., Hoffer, B. J., Goetzl, E. J., Kapogiannis, D., & Greig, N. H. (2020) · eLife · doi:10.7554/elife.55827 · Cited by 45
Neuroinflammation in Prion Disease
Li, B., Chen, M., & Zhu, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042196 · Cited by 54
Microglia Drive Pockets of Neuroinflammation in Middle Age
Moca, E. N., Lecca, D., Hope, K. T., Etienne, F., Schaler, A. W., Espinoza, K., Chappell, M. S., Gray, D. T., Tweedie, D., Sidhu, S., et al. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1922-21.2022 · Cited by 42
Intra‐neural administration of fractalkine attenuates neuropathic pain‐related behaviour
Holmes, F. E., Arnott, N., Vanderplank, P., Kerr, N. C. H., Longbrake, E. E., Popovich, P. G., Imai, T., Combadière, C., Murphy, P. M., & Wynick, D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05419.x · Cited by 42
“…cells in the spinal cord most likely represent resident microglia as previously described in the rat (Verge et al. 2004; Lindia et al. 2005; Cardona et al. 2006), though it is possible that invading peripheral macrophages may also contribute to the observed staining, as suggested by Hu et…”
BackgroundStone, T. W., & Williams, R. O. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16015 · Cited by 49
“…are included among those produced by neurons, including fractalkine (CX3CL1) (Lai & Mueller, 2021; Sawant et al., 2021 ; Ubogu et al., 2006 ), which suppresses microglial activity, and whose absence results in developmental abnormalities of the CNS (Cardona et al., 2006 ; Harrison et al., 1998 ).”
Isolation and Analysis of Mouse Microglial Cells
Garcia, J. A., Cardona, S. M., & Cardona, A. E. (2014) · Current Protocols in Immunology · doi:10.1002/0471142735.im1435s104 · Cited by 41
Self-citationThe innate and adaptive immunological aspects in neurodegenerative diseases
Rodrigues, M. C. O., Sanberg, P. R., Cruz, L. E. G., & Garbuzova-Davis, S. N. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.020 · Cited by 48
“Neuron–microglia interaction includes the fractalkine (CX3CL1)– fractalkine receptor (CX3CR1) pathway, signals along which restrict microglial activation (Cardona et al., 2006).”
BackgroundFaustino, J., Chip, S., Derugin, N., Jullienne, A., Hamer, M., Haddad, E., Butovsky, O., Obenaus, A., & Vexler, Z. S. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18817663 · Cited by 41
Tajbakhsh, A., Read, M., Barreto, G. E., Ávila-Rodriguez, M., Gheibi-Hayat, S. M., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41
El-Derany, M. O., & Noureldein, M. H. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02384-9 · Cited by 42
“In fact, Cx3cr1 receptors are reported to be expressed on the microglia, besides, its ligand, Cx3cl1, can act directly on neurons through Cx3cr1 receptors as well, to activate different neuronal survival pathways [76].”
BackgroundRapid isolation and culture of primary microglia from adult mouse spinal cord
Yip, P. K., Kaan, T. K. Y., Fenesan, D., & Malcangio, M. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.07.002 · Cited by 45
Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα
Rutti, S., Arous, C., Schvartz, D., Timper, K., Sanchez, J.-C., Dermitzakis, E., Donath, M. Y., Halban, P. A., & Bouzakri, K. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.07.007 · Cited by 39
“Reporter gene studies h ave shown that CX3CL1 is principally expressed in neurons, lung epithelial cells, kidney and in the intestine [13-15], whereas CX3CR1 is mainly expressed in monocytes, natural killer ce lls and T cells [15, 16].”
BackgroundNeuronal influence behind the central nervous system regulation of the immune cells
Chavarría, A., & Cárdenas, G. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00064 · Cited by 40
“CX3CL1 can be found membrane-anchored or secreted both in physiological and pathological conditions such as facial motor nerve axotomy or a toxic model of Parkinson’s disease (Harrison et al., 1998; Cardona et al., 2006).”
BackgroundLee, H. C., Gaire, J., Currlin, S., McDermott, M. D., Park, K., & Otto, K. J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00513 · Cited by 45
“demonstrated that CX3CR1 deficient mice either stimulated with lipopolysaccharide (LPS), given neurotoxins to induce Parkinson’s disease symptoms, or genetically modified to induce amyotrophic lateral sclerosis resulted inmore neurodegeneration than controls (Cardona et al., 2006).”
BackgroundZhou, Y., Zhang, L., Hao, Y., Liu, Y., Fan, S., & Xiao, Z. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01416-w · Cited by 45
“FKN is a chemokine expressed by both neurons and glia, and its receptor, CX3CR1, is primarily expressed on microglia [18].”
BackgroundSuzuki, M., El‐Hage, N., Zou, S., Hahn, Y.-K., Sorrell, M. E., Sturgill, J., Conrad, D. H., Knapp, P. E., & Hauser, K. F. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-78 · Cited by 38
“Notwithstanding its chemotactic and surveillance functions [28,37], fractalkine is reported to limit cytotoxicity by reducing microglial activation and killing [30,37,38].”
BackgroundInfluentialNeuroinflammation and the plasticity-related immediate-early gene Arc
Rosi, S. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.003 · Cited by 40
“Disruption of FKN-CX3CR1 signalling has been shown to exacerbate neurotoxicity in animal models of many neuropathological disorders, including AD (Cardona et al., 2006).”
BackgroundMicroglial activation mediates host neuronal survival induced by neural stem cells
Wu, H., Zhang, L., Ding, P., Liu, Y., Wu, X., & Zhou, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12281 · Cited by 43
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.